These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 33376700

  • 1. Efficacy, Safety, and Cost Evaluation of the Topical Luliconazole Therapy versus Topical Clotrimazole Therapy in Patients with Localized Dermatophytosis in a Tertiary Care Hospital: An Observational Study.
    Kaur M, Gupta A, Mahajan R, Gill M.
    Int J Appl Basic Med Res; 2020; 10(4):260-264. PubMed ID: 33376700
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis.
    Banerjee M, Ghosh AK, Basak S, Das KD, Gangopadhyay DN.
    Indian J Dermatol; 2011 Nov; 56(6):657-62. PubMed ID: 22345765
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.
    Rana DK, Shah TS, Rohit MH, Patel NH, Khadela AD, Oza YP, Padhiyar JK.
    Mycoses; 2024 Jan; 67(1):e13681. PubMed ID: 38214352
    [Abstract] [Full Text] [Related]

  • 4. Luliconazole for the treatment of fungal infections: an evidence-based review.
    Khanna D, Bharti S.
    Core Evid; 2014 Jan; 9():113-24. PubMed ID: 25285056
    [Abstract] [Full Text] [Related]

  • 5. Comparing emollient use with topical luliconazole (azole) in the maintenance of remission of chronic and recurrent dermatophytosis. An open-label, randomized prospective active-controlled non-inferiority study.
    Pathania YS, Cds K, Kumar A.
    Mycoses; 2024 Jan; 67(1):e13659. PubMed ID: 37837226
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study.
    Chatterjee D, Ghosh SK, Sen S, Sarkar S, Hazra A, De R.
    Indian J Pharmacol; 2016 Jan; 48(6):659-664. PubMed ID: 28066103
    [Abstract] [Full Text] [Related]

  • 7. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris.
    Jones TM, Jarratt MT, Mendez-Moguel I, Paz N, Grekin SK, Cognata Smith C, Kaur M.
    J Drugs Dermatol; 2014 Jan; 13(1):32-8. PubMed ID: 24385117
    [Abstract] [Full Text] [Related]

  • 8. Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of tinea corporis-an observational study.
    Shivamurthy RP, Reddy SG, Kallappa R, Somashekar SA, Patil D, Patil UN.
    J Clin Diagn Res; 2014 Sep; 8(9):HC09-12. PubMed ID: 25386455
    [Abstract] [Full Text] [Related]

  • 9. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections.
    Baghel S, Nair VS, Pirani A, Sravani AB, Bhemisetty B, Ananthamurthy K, Aranjani JM, Lewis SA.
    Dermatol Ther; 2020 Nov; 33(6):e13959. PubMed ID: 32618400
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
    Jarratt M, Jones T, Adelglass J, Bucko A, Pollak R, Roman-Miranda A, Olin JT, Swinyer L.
    J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
    [Abstract] [Full Text] [Related]

  • 12. A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections.
    Gupta AK, Daigle D.
    Infect Drug Resist; 2016 Jul; 9():1-6. PubMed ID: 26848272
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study.
    Dakhale GN, Gupta AV, Mukhi JI, Kalikar MV.
    Perspect Clin Res; 2021 Jul; 12(4):223-228. PubMed ID: 34760651
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
    Tahiliani S, Saraswat A, Lahiri AK, Shah A, Hawelia D, Shah GK, Girdhar M, Rao PN, Raghav PA, Agarwal P, Kharkar RD, Gupta RP, Udare S, Hegde S, Haldar S.
    Indian J Dermatol Venereol Leprol; 2021 Jul; 87(6):800-806. PubMed ID: 34160163
    [Abstract] [Full Text] [Related]

  • 19. New Antifungal Agents and New Formulations Against Dermatophytes.
    Gupta AK, Foley KA, Versteeg SG.
    Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial.
    Rao MKP, Siddananjappa L, Sidana N, Deshmukh A, Diwari B, Podder I, Kumar S, Mittal R, Daultani P, Jaiswal A, Chinda M.
    Cureus; 2024 May; 16(5):e60162. PubMed ID: 38868264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.